2m 2m 2m 2m 2m 2m 2m
Syndax Pharmaceu (SNDX)
NASDAQ
$18.10-$0.08 (-0.44%)
Price as of Sep 11, 2026 7:30 PM EDT- $1.6BMarket Cap
- 16.91%1-Year Change
- BiotechnologyIndustry
Syndax Pharmaceu (SNDX)
$18.10-$0.08 (-0.44%)
SNDX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $18.18 | ||
Change | -$0.64 (-3.40%) | ||
Open | $19.01 | ||
High | $19.02 | ||
Low | $18.02 | ||
Previous Close | $18.82 | ||
Volume | 1,223,261 | ||
30-Day Average Volume | 1,269,699 | ||
1-Week Change | -11.58% | ||
1-Month Change | -10.40% | ||
1-Year Change | 16.91% | ||
3-Year Change | 4.72% | ||
5-Year Change | -0.66% | ||
Fundamentals | |||
Shares Outstanding | 89.3M | ||
Total Assets | $703.7M | ||
Market Cap | $1.6B | ||
Enterprise Value | $2.5B | ||
Period: QTR TTM FY | |||
Revenue | $54.7M | ||
Net Income | -$49.4M | ||
Free Cash Flow | -$30.3M | ||
EBIT | -$37.3M | ||
EBITDA | -$32.3M | ||
Net Working Capital | $575.4M | ||
EPS | -$0.55 | ||
Enterprise Value/EBITDA | -77 | ||
Enterprise Value/Revenue | 45 | ||
P/B | 108 | ||
P/E | -33 | ||
PEG | 2 | ||
Price/Free Cash Flow | -54 | ||
Price/Operating Cash Flow | -54 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue